Desoximetasone 0.05% twice daily: Clinical Trials

1 trial of Desoximetasone 0.05% twice daily, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Desoximetasone 0.05% twice daily: new trials by email Literature Review of Desoximetasone 0.05% twice daily trials Research Report on Desoximetasone 0.05% twice daily

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study
Desoximetasone 0.05% once daily, Desoximetasone 0.05% twice daily, Desoximetasone 0.25% once daily - Psoriasis
Phase 2CompletedSun Pharmaceutical Industries, Inc.1512009-11-012014-08-05

Conditions studied

Psoriasis (1)

Sponsors

Sun Pharmaceutical Industries, Inc. (1)

Countries

United States (1)